GSK
GSK
GSK
918 hedge funds and large institutions have $14.4B invested in GSK in 2021 Q4 according to their latest regulatory filings, with 193 funds opening new positions, 320 increasing their positions, 247 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
17% more capital invested
Capital invested by funds: $12.4B → $14.4B (+$2.04B)
16% more funds holding
Funds holding: 791 → 918 (+127)
0.07% more ownership
Funds ownership: 5.14% → 5.21% (+0.07%)
Holders
918
Holding in Top 10
19
Calls
$624M
Puts
$233M
Top Buyers
| 1 | +$185M | |
| 2 | +$156M | |
| 3 | +$65.3M | |
| 4 |
Goldman Sachs
New York
|
+$60.2M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$57.3M |
Top Sellers
| 1 | -$268M | |
| 2 | -$156M | |
| 3 | -$107M | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
-$94.2M |
| 5 |
Two Sigma Investments
New York
|
-$67.7M |